Lexeo Therapeutics, Inc. Common Stock (LXEO): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 20,889 US Dollar | 4 | 3 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 78.521.634 | 24,47 | 15,14 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Lexeo Therapeutics, Inc. Common Stock
Mitarbeiter 59
Handelsplatz NASDAQ
Ticker Symbol LXEO
IPO Datum 2023-11-03
Adresse 345 Park Avenue South, New York, NY, United States, 10010
Webseite https://www.lexeotx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. R. Nolan Townsend M.B.A. | CEO & Director |
| 2 | Mr. Louis Tamayo | CFO & Principal Accounting Officer |
| 3 | Dr. Ronald G. Crystal M.D. | Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board |
| 4 | Dr. Jose Manuel Otero Ph.D. | Chief Operating Officer |
| 5 | Dr. Eric Adler M.D. | Advisor |
| 6 | Dr. Narinder P. Bhalla FACC, FSCAI, M.D. | Chief Medical Officer |
| 7 | Mr. Keith Wonnacott | Senior Vice President of Regulatory Affairs |
| 8 | Ms. Ashley Kaplowitz | Head of Capital Markets |
| 9 | Mr. Ryan McHenry | VP & Corporate Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Paradigm Biocapital Advisors LP | 7,88% | 28,82 Mio. USD |
| 2 | BlackRock Inc | 6,51% | 23,82 Mio. USD |
| 3 | Affinity Asset Advisors, LLC | 6,43% | 23,53 Mio. USD |
| 4 | RA Capital Management, LLC | 6,37% | 23,30 Mio. USD |
| 5 | HHG PLC | 6,34% | 23,19 Mio. USD |
| 6 | Vestal Point Capital LP | 5,70% | 20,85 Mio. USD |
| 7 | Frazier Life Sciences Management, L.P. | 5,64% | 20,62 Mio. USD |
| 8 | Vanguard Group Inc | 4,96% | 18,15 Mio. USD |
| 9 | Citadel Advisors Llc | 4,88% | 17,87 Mio. USD |
| 10 | Orbimed Advisors, LLC | 4,59% | 16,79 Mio. USD |
| 11 | State Street Corp | 4,54% | 16,63 Mio. USD |
| 12 | Vanguard Capital Management, LLC | 3,83% | 14,01 Mio. USD |
| 13 | Woodline Partners LP | 3,50% | 12,82 Mio. USD |
| 14 | The Goldman Sachs Group Inc | 2,48% | 9,09 Mio. USD |
| 15 | venBio Select Advisor LLC | 2,39% | 8,74 Mio. USD |
| 16 | Point72 Asset Management, L.P. | 2,14% | 7,83 Mio. USD |
| 17 | Millennium Management LLC | 2,05% | 7,52 Mio. USD |
| 18 | Balyasny Asset Management LLC | 2,02% | 7,41 Mio. USD |
| 19 | Geode Capital Management, LLC | 1,93% | 7,05 Mio. USD |
| 20 | ADAR1 Capital Management LLC | 1,87% | 6,84 Mio. USD |